LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform) General Information

Description

An anticancer therapeutic vaccine platform. The platform offers a technology that can be applied to anticancer therapeutic vaccines in the form of recombinant proteins.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • LG Twin Towers, 128
  • Yeoui-daero
  • Seoul, Yeongdeungpo-gu
  • South Korea
+82
Primary Industry
Buildings and Property
Other Industries
Biotechnology
Acquirer
Corporate Office
  • LG Twin Towers, 128
  • Yeoui-daero
  • Seoul, Yeongdeungpo-gu
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform)‘s full profile, request access.

Request a free trial

LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform)‘s full profile, request access.

Request a free trial

LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform) FAQs

  • Where is LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform) headquartered?

    LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform) is headquartered in Seoul, South Korea.

  • What industry is LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform) in?

    LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform)’s primary industry is Buildings and Property.

  • Is LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform) a private or public company?

    LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform) is a Private company.

  • What is LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform)’s current revenue?

    The current revenue for LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform) is .

  • Who are LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform)’s investors?

    LG Chem has invested in LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform).

  • When was LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform) acquired?

    LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform) was acquired on 18-Nov-2024.

  • Who acquired LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform)?

    LG Chem (Global Development and Commercialization Rights of Anticancer Therapeutic Vaccine Platform) was acquired by Arkgen Bioscions.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process